Patients
gather to praise minimally
invasive technique used in treating tumors
By MICHELLE BRANDT
When Jeanie Schmidt, a critical
care nurse from Foster City, lost hearing in her left ear and
experienced numbing in her face, she prayed that her first
instincts were off. “I said to the doctor, `I think I have an
acoustic neuroma (a brain tumor), but I'm hoping I'm wrong. Tell me
it's wax, tell me it's anything,'” Schmidt
recalled.
It wasn't wax, however, and
Schmidt – who wound up in the Stanford Hospital emergency
room when her symptoms worsened – was quickly forced to make
a decision regarding treatment for her tumor.
On July 13, Schmidt found herself
back at Stanford – but this time with a group of patients who
were treated with the same minimally invasive treatment that
Schmidt ultimately chose: the CyberKnife. She was one of 40 former
patients who met with Stanford faculty and staff to discuss their
experiences with the CyberKnife – a radiosurgery system
designed at Stanford by John Adler Jr., MD, in 1994 for performing
neurosurgeries without incisions.
“I wanted the chance to
thank everyone again and to share experiences with other
patients,” said Schmidt, who had the procedure on June 20 and
will have an MRI in six months to determine its effectiveness.
“I feel really lucky that I came along when this technology
was around.”
The CyberKnife is the newest
member of the radiosurgery family. Like its ancestor, the
33-year-old Gamma Knife, the CyberKnife uses 3-D computer targeting
to deliver a single, large dose of radiation to the tumor in an
outpatient setting. But unlike the Gamma Knife – which
requires patients to wear an external frame to keep their head
completely immobile during the procedure – the CyberKnife can
make real-time adjustments to body movements so that patients
aren't required to wear the bulky, uncomfortable head
gear.
The procedure provides patients an
alternative to both difficult, risky surgery and conventional
radiation therapy, in which small doses of radiation are delivered
each day to a large area. The procedure is used to treat a variety
of conditions – including several that can't be treated by
any other procedure – but is most commonly used for
metastases (the most common type of brain tumor in adults),
meningomas (tumors that develop from the membranes that cover the
brain), and acoustic neuromas. Since January 1999, more than 335
patients have been treated at Stanford with the
CyberKnife.
The July 13 meeting began with a
presentation by Adler, who provided an historical oversight of
radiosurgery and expressed gratitude to the patients who chose to
undergo the procedure. “I feel very proud of what I've done,
but how can I not appreciate the courage of these patients?”
said Adler, professor of neurosurgery and director of radiosurgery
and stereotactic surgery at Stanford. “Because of them,
patients all over the world are having their surgeries done
differently.”
Patients also took turns at the
podium. Valerie DeGrendele described the years of pain she endured.
From the age of 13, DeGrendele experienced frequent episodes of
feeling like someone was “repeatedly stabbing me in the
neck,” followed by paralysis of her right side. Doctors
couldn't determine what was wrong with her, and the family
chiropractor told her parents that she would be paralyzed for the
rest of her life. Other doctors said there was nothing they could
do for her. It wasn't until years later, when she was diagnosed as
having an arteriovenous malformation – dangerous masses of
abnormal blood vessels – on her spinal cord that she was
referred to Adler.
“It was the first time in my
life that anyone offered me hope,” DeGrendele said. She had
the procedure (“I was in and out of there faster than it
takes to go grocery shopping,” she noted) and the
malformation has since shrunk by 75 percent.
Donald Sabin, a former patient who
emceed the event, announced the formation of a patient support
group that will not only serve as a resource for CyberKnife
patients but will also educate others about the procedure.
“We need to take an oath as patients to get the message
across that a minimally invasive treatment is available,” he
said.
|